O'Shaughnessy Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,887	Closed	-$79K	–	2788
2021 Q3	$79K	Sell	3,887 -763	-16%	-$21.1K	﹤0.01%	1471
2021 Q2	$173K	Hold	4,650	–	–	﹤0.01%	1098
2021 Q1	$119K	Sell	4,650 -13,038	-74%	-$333K	﹤0.01%	1125
2020 Q4	$390K	Buy	17,688 +2,465	+16%	+$54.3K	0.01%	590
2020 Q3	$275K	Sell	15,223 -1,612	-10%	-$33.4K	0.01%	604
2020 Q2	$428K	Sell	16,835 -4,184	-20%	-$90.1K	0.01%	434
2020 Q1	$388K	Buy	21,019 +12,617	+150%	+$245K	0.01%	333
2019 Q4	$185K	Buy	+8,402	New	+$169K	﹤0.01%	640

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

O'Shaughnessy Asset Management's DRNA Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 3,887 shares — an estimated $79K sold.

O'Shaughnessy Asset Management first reported a position in DRNA in Q4 2019 and held it in 8 quarters. The position peaked at $428K in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 3,887 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $79K.
O'Shaughnessy Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 8 quarters.
O'Shaughnessy Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $428K in Q2 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.